BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BAYN - DE000BAY0017 - Common Stock
30.69 EUR
-0.17 (-0.55%)
Taking everything into account, 1BAYN scores 3 out of 10 in our fundamental rating. 1BAYN was compared to 55 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of 1BAYN have multiple concerns. 1BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
1BAYN had positive earnings in the past year.
1BAYN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
Each year in the past 5 years 1BAYN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of 1BAYN (-3.25%) is worse than 65.45% of its industry peers.
With a Return On Equity value of -11.25%, 1BAYN is not doing good in the industry: 65.45% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of 1BAYN has declined.
With a Gross Margin value of 54.95%, 1BAYN is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of 1BAYN has declined.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
1BAYN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for 1BAYN remains at a similar level compared to 5 years ago.
1BAYN has a better debt/assets ratio than last year.
2.2 Solvency
1BAYN has an Altman-Z score of 0.81. This is a bad value and indicates that 1BAYN is not financially healthy and even has some risk of bankruptcy.
1BAYN has a worse Altman-Z score (0.81) than 72.73% of its industry peers.
1BAYN has a debt to FCF ratio of 8.37. This is a slightly negative value and a sign of low solvency as 1BAYN would need 8.37 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.37, 1BAYN is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.04 is on the high side and indicates that 1BAYN has dependencies on debt financing.
1BAYN's Debt to Equity ratio of 1.04 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.81 |
ROIC/WACCN/A
WACC6.71%
2.3 Liquidity
1BAYN has a Current Ratio of 1.13. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1BAYN (1.13) is worse than 69.09% of its industry peers.
A Quick Ratio of 0.73 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN's Quick ratio of 0.73 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 74.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
1BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
The Revenue has decreased by -2.16% in the past year.
Measured over the past years, 1BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
1BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.48% yearly.
Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.44% on average per year.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.48%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.44%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.75, which indicates a rather cheap valuation of 1BAYN.
Based on the Price/Earnings ratio, 1BAYN is valued cheaply inside the industry as 96.36% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.15. 1BAYN is valued rather cheaply when compared to this.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 6.30.
Based on the Price/Forward Earnings ratio, 1BAYN is valued cheaper than 94.55% of the companies in the same industry.
1BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.75 | ||
| Fwd PE | 6.3 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BAYN indicates a somewhat cheap valuation: 1BAYN is cheaper than 72.73% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaper than 94.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.57 | ||
| EV/EBITDA | 9.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
5. Dividend
5.1 Amount
With a yearly dividend of 0.41%, 1BAYN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.00, 1BAYN is paying slightly less dividend.
With a Dividend Yield of 0.41, 1BAYN pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
BIT:1BAYN (11/26/2025, 7:00:00 PM)
30.69
-0.17 (-0.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.15B
Revenue(TTM)46.61B
Net Income(TTM)-3.42B
Analysts71.43
Price Target29.59 (-3.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)2.27%
PT rev (3m)1.76%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)-5.7%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.75 | ||
| Fwd PE | 6.3 | ||
| P/S | 0.65 | ||
| P/FCF | 6.57 | ||
| P/OCF | 4.22 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.41 |
EPS(TTM)5.34
EY17.4%
EPS(NY)4.87
Fwd EY15.88%
FCF(TTM)4.67
FCFY15.23%
OCF(TTM)7.28
OCFY23.71%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.81 |
F-Score4
WACC6.71%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.44%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.27%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / 1BAYN.MI FAQ
What is the fundamental rating for 1BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI.
What is the valuation status for 1BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Undervalued.
Can you provide the profitability details for BAYER AG-REG?
BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.
What is the earnings growth outlook for BAYER AG-REG?
The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -6.5% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (1BAYN.MI) is 0 / 10 and the dividend payout ratio is -3.69%.